Investigational Site Number 840006

Augusta, Georgia 30912

0 studies enrolling now · 3 studies all time

What they study most

Chronic Lymphocytic Leukemia, Indolent Non-Hodgkin Lymphoma, Lymphoma, Mantle Cell Lymphoma, Neoplasm Malignant

Studies at this site

• Open Label Treatment Extension Study With SAR245408 or SAR245409 as a Monotherapy or as a Combination Regimen — Completed
• Study Combining SAR245409 With Rituximab or Bendamustine Plus Rituximab in Patients With Indolent Lymphoma, Mantle Cell Lymphoma and Chronic Lymphocytic Leukemia — Completed
• A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia — Completed